Navigation Links
Eamonn Hobbs Joins the Board of Directors at Cappella
Date:2/17/2010

cal need. Whereas long under-diagnosed and under-served, bifurcational lesions have now attracted the much deserved attention of the medical community and I am convinced that Cappella has put the best team on the field to tackle the challenge. I am thrilled to work with Dr. Art Rosenthal and our Board of Directors to deliver this technology to patients in need."

About Cappella, Inc.

Cappella, Inc. is a medical device company, developing novel solutions for the treatment of complex Coronary Artery Disease (CAD) and specifically bifurcation vascular disease. Cappella's initial product, the Sideguard(R) (http://www.cappella-med.eu/index.php?option=com_content&view=article&id=1&Itronary Sidebranch Stent & Delivery System offers interventional cardiologists a straightforward, effective solution that focuses on treating the sidebranch of diseased coronary arteries first, rather than the main vessel. More importantly, it allows the preferred stent of choice for the main vessel. An optimal stent design specific to the anatomy of the sidebranch, combined with the qualities of Nitinol now provide a dynamic solution for treating sidebranch disease. Cappella Medical Devices Ltd., Galway, Ireland is the R&D and manufacturing subsidiary of Cappella, Inc. For more information, see: http://www.cappella-med.com.

(Due to the length of some of the URLs in
'/>"/>

SOURCE Cappella Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Former Air Force Surgeon General Joins Integrated Medical Systems Advisory Board
2. Anthera Pharmaceuticals Announces Agreement With the FDA on a SPA for Planned Phase 3 Varespladib A-002 Study; Daniel K. Spiegelman Joins Board of Directors
3. Steven Leventer Joins PharmaNet Development Group as Vice President, Clinical Research Neuroscience
4. New Life Agency, Inc. Joins Forces With The Diamond Institute and Walgreens Specialty Pharmacy to Introduce the Nations First In Vitro Fertilization Insurance Program
5. CooperVision Adds Global Professional Relations Role; Richard Clompus Joins Company as Vice President
6. Professor Riccardo Lencioni Joins Delcath Systems Scientific Advisory Board
7. Royalty Pharma Announces that Alexander von Perfall Joins Management Team
8. Howard Goldstein Joins Microchip Biotechnologies, Inc. as Executive Vice President
9. Scott Glenn Joins Exagen Diagnostics as Chairman and CEO
10. PFC Pharma Joins DATATRAKs CRO Connect Program
11. William Cork Joins Fenwal as Chief Technology Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/30/2015)... April 30, 2015 /PRNewswire/ - Pivotal Therapeutics Inc. ... with a focus on Omega-3 therapies for cardiovascular ... highlights and financial results for the fiscal year ... herein are in Canadian dollars unless otherwise stated. ... significant, with the right strategic partners and additional ...
(Date:4/30/2015)... , April 30, 2015  IRIDEX Corporation (NASDAQ: ... first quarter 2015 financial results after the market closes ... with the release, the Company will host a conference ... Eastern Time on Thursday, May 7, 2015 ... other business developments. Interested parties may access ...
(Date:4/30/2015)... -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX ) announced today ... after the market closes on Thursday, May 7, 2015.  ... held on Thursday, May 7, 2015, at 4:30 p.m. ... participate in the call, please dial 877-303-1298 (for U.S. ... the teleconference will be available for one week and ...
Breaking Medicine Technology:Pivotal Therapeutics Announces 2014 Financial Results 2Pivotal Therapeutics Announces 2014 Financial Results 3Pivotal Therapeutics Announces 2014 Financial Results 4Pivotal Therapeutics Announces 2014 Financial Results 5Pivotal Therapeutics Announces 2014 Financial Results 6IRIDEX Announces First Quarter 2015 Conference Call and Release Date 2Cumberland Pharmaceuticals To Announce First Quarter 2015 Financial Results 2
... FOREST, Ill., March 9, 2011 Hospira, Inc. (NYSE: ... today announced U.S. Food and Drug Administration (FDA) approval of ... and Hospira expects to launch the product later this month. ... a variety of cancers. In 2010, U.S. sales of Taxotere ...
... Tris Pharma, a specialty pharmaceutical company that develops ... US Food and Drug Administration (FDA) has accepted ... the treatment of allergies in kids two years ... Suspension will provide an alternative to the currently ...
Cached Medicine Technology:Hospira Announces U.S. Approval of Generic Docetaxel 2Tris Announces NDA Acceptance of Extended Release Carbinoxamine Oral Suspension for the Treatment of Allergies in Kids Two Years and Older 2
(Date:5/2/2015)... As one of only 30 Illinois ... and Health Achievement and Recognition Program (SHARP) certification, ... by the Illinois Department of Labor to host this ... SHARP certification by the Occupational Safety and Health Administration’s ... continued to meet or exceed all of the necessary ...
(Date:5/2/2015)... 02, 2015 It’s a pattern that ... disaster strikes anywhere on this planet, cyber scammers will ... and compassion for their own personal gain. And ... Readiness Team) issued an alert titled “Nepal Earthquake ... scams citing the earthquake in Nepal. The scam emails ...
(Date:5/2/2015)... May 02, 2015 As a ... issues of the face, neck and décolleté, radiofrequency ... with real potential for the success of vulvovaginal ... ThermiHealth Clinical Advisory Council, ThermiGyn’s Women’s Health Clinical ... ACGE, concluded that ThermiGyn’s temperature controlled radio frequency, ...
(Date:5/1/2015)... Farmington NY (PRWEB) May 01, 2015 ... world, will share the latest in their reclaimed wood ... (ICFF) at the Jacob Javits Center in NYC this ... Prairie Boards, will bring much anticipated texture and color ... “We've seen an explosion of texture and color in ...
(Date:5/1/2015)... May 01, 2015 It’s raining bills on ... introducing proposals to expand federal support for telemedicine. ... ATA has been working with Congress,” said Jonathan Linkous, CEO ... how the nation is poised to embrace the use of ... more step in fulfilling ATA’s mission to improve quality, access, ...
Breaking Medicine News(10 mins):Health News:Essentra Specialty Tapes is Selected to Host Gov. Rauner and the Workers' Memorial Day Celebration 2Health News:Essentra Specialty Tapes is Selected to Host Gov. Rauner and the Workers' Memorial Day Celebration 3Health News:Cyber Aftershocks from Nepal’s Earthquake Can Cripple Businesses Right Here at Home 2Health News:Cyber Aftershocks from Nepal’s Earthquake Can Cripple Businesses Right Here at Home 3Health News:Cyber Aftershocks from Nepal’s Earthquake Can Cripple Businesses Right Here at Home 4Health News:Study Demonstrates Efficacy of Temperature Controlled Radiofrequency for Vulvovaginal Laxity 2Health News:Study Demonstrates Efficacy of Temperature Controlled Radiofrequency for Vulvovaginal Laxity 3Health News:Intensely Textured Reclaimed Wood to be Unveiled at ICFF in NYC by Pioneer Millworks 2Health News:Intensely Textured Reclaimed Wood to be Unveiled at ICFF in NYC by Pioneer Millworks 3Health News:ATA: Congress Floods the Halls with Telemedicine Proposals 2
... The American Board of Internal Medicine,(ABIM) ... Corporation,s (MSC) SimSuite(R) technology, for credit toward,completion ... first time ABIM is,incorporating medical simulation technology ... SimSuite technology replicates a real-life catheterization lab, ...
... Feb. 4 - Is it safe to wait to ... you,ve waited and,waited for all the doctor appointments and ... of being cured? Reassuring research,says that men can take ... February 2008 issue of Harvard Men,s Health Watch., ...
... caregivers offers tips to families, friends, caregivers and ... ... Feb. 4 What do you say, what can you do ... a serious,disease? To kick-off National Patient Recognition Week, a week-long,observance beginning ...
... million women around the world, including an estimated 50,000 ... developed by Georgetown University Medical Centers Institute for Reproductive ... use CycleBeads a visual aid developed by the Institute ... prevent pregnancy. , Now CycleBeads are available in ...
... February 4, 2007 -- New York Methodist Hospital today ... for Emphysema) Trial, an international, multi-center clinical trial to ... new, minimally-invasive option for those suffering with advanced widespread ... bypass that involves creating pathways in the lung for ...
... Syndrome (TCS), the Stowers Institutes Trainor Lab has demonstrated that ... by inactivating a gene implicated in the abnormality or by ... posted to the Web site of the journal Nature Medicine ... the cellular cause of TCS. , The team evaluated ...
Cached Medicine News:Health News:Medical Simulation Corporation and the American Board of Internal Medicine Introduce New Simulation for Physician Assessment and Evaluation 2Health News:Men Can Take Their Time to Decide on Prostate Cancer Treatment, Reports the Harvard Men's Health Watch 2Health News:It's National Patient Recognition Week - Here's How You Can Do Something Special for Someone Facing Illness 2Health News:It's National Patient Recognition Week - Here's How You Can Do Something Special for Someone Facing Illness 3Health News:CycleBeads help women manage their fertility 2Health News:New York Methodist Hospital to study airway bypass treatment for emphysema 2Health News:Trainor Lab prevents rare birth defect by inactivating p53 gene 2
Cushing Flat Drill, only Component Parts and Accessories for HUDSON Cranial Drill. 14 mm...
Hudson brace only. Component parts and accessories for Hudson cranial drill....
Greenberg micro instrument holder is a flexbar arm used to hold micro instruments used repeatedly within retracted fields. Holds instruments with shafts up to 1/8 in diameter....
Length-9 (229 mm) Tapered retractor blades....
Medicine Products: